NASDAQ:CARA Has been consolidating for over 5 years now and is flirting with its ATH.
The promising biotech company only has a market cap of 1B which makes a 5x move very easy and fast. This is more of a longer-term play and can increase well over 5x
Stock may dip before the meteoric rise but hard to say with earnings coming first week of August.